HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Self-Care Medical Devices Sitting In The ‘Danger Zone,’ AESGP Warns

Executive Summary

The Association of the European Self-Medication Industry (AESGP) warns that many self-care medical devices could fall through the cracks of implementing new EU regulations, as the deadline draws near. 

You may also be interested in...

Self-Care Devices May See Extension After EU Commission Admits MDR ‘Inconsistencies’

Self-care medical devices may be included in the four-year “grace period” following implementation of the new EU Medical Devices Regulation as part of an incoming corrigendum to the law, a spokesperson for the European Commission suggested at a recent AESGP meeting.

AESGP Regulatory Conference: No Progress On Botanicals, MDR Tensions Mount

A lack of progress on the botanical health claims issue and rising tensions with the impending Medical Devices Regulation were among the topics discussed at the AESGP's Regulatory Conference in Brussels yesterday. 

To Ensure Continued Availability Of Self-Care Devices In Europe, EU Commission Must 'Stop The Clock' On MDR

As the implementation deadline for the European Union's Medical Devices Regulation creeps ever closer, substance-based medical devices such as nasal sprays and throat lozenges are in danger of slipping through the net of re-certification. TÜV SÜD, one of only four notified bodies to be approved for re-certification under the new rules, says the EU should "stop the clock" on implementation to ensure these products continue to be available in Europe after the deadline. 

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts